PRISCILLA LAMBERTI: Open Payments
NPI 1396447462 · TRINITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,945 in 153 payments from 38 companies in 2025. Trend: 2023 $33 · 2024 $1,161 · 2025 $3,945
Food & beverage: $3,078Long term medical supply or device loan: $698Education: $169
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 24 | $952 |
| Janssen Biotech, Inc. | 13 | $297 |
| Merck Sharp & Dohme LLC | 10 | $246 |
| Gilead Sciences, Inc. | 7 | $199 |
| GlaxoSmithKline, LLC. | 11 | $194 |
| Regeneron Healthcare Solutions, Inc. | 6 | $174 |
| Daiichi Sankyo Inc. | 7 | $173 |
| GENZYME CORPORATION | 7 | $156 |
| PFIZER INC. | 7 | $119 |
| AstraZeneca Pharmaceuticals LP | 5 | $116 |
Products named: KISQALI, KEYTRUDA, RYBREVANT, Trodelvy, LIBTAYO, ENHERTU, OJJAARA, SARCLISA.
Industry payments across FL — which companies pay providers there.
